Experienced in Collagen VI-Related Myopathy

Fransiska Malfait

Gent, VLG, BE 
Experienced in Collagen VI-Related Myopathy
Gent, VLG, BE 
OverviewLocationsClinical Research

Overview

Fransiska Malfait practices in Gent, Belgium. Malfait is rated as an Experienced expert by MediFind in the treatment of Collagen VI-Related Myopathy. Their top areas of expertise are Ehlers-Danlos Syndrome (EDS), Cutis Laxa, Hypermobile Joints, and Vascular Ehlers-Danlos Syndrome (VEDS).

Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Collagen VI-Related Myopathy.

Locations

Gent, VLG 9000, Belgium
Other Locations
Leuven, VLG 3000, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Effectiveness of a 6-month Home-based Exercise Program for Treating Shoulder Instability in Patients With Hypermobile Ehlers-Danlos Syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD): A Pilot Randomized Controlled Trial.
Effectiveness of a 6-month Home-based Exercise Program for Treating Shoulder Instability in Patients With Hypermobile Ehlers-Danlos Syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD): A Pilot Randomized Controlled Trial.
Enrollment Status: Terminated
Publish Date: March 22, 2021
Intervention Type: Other
Study Phase: Not Applicable

136 Total Publications

Correction: The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome.
Correction: The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome.
Journal: Cell death discovery
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Malfait's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile